MedTrace Logo

Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases

NCT02085681 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 801

Last updated 2015-04-22

No results posted yet for this study

Summary

The aim of this study is to compare the effectiveness of identifying diabetic retinopathy using tele-medicine based Digital Retinal Imaging in Diabetes Clinics with that of the conventional referral system.

Hypothesis: Tele-medicine based digital retinal imaging involving a diabetes centre will identify proportionately more diabetic patients with DR and lead to higher acceptance rate with subsequent ophthalmic referral and management

Conditions

Interventions

OTHER

Tele-medicine

Patients at the diabetes clinics will be subjected to non-mydriatic retinal imaging and the images will be transferred to the eye hospital via internet using a specified software - Aravind Diabetic Retinopathy Evaluation Software (ADRES) that enables a retinal specialist to read and grad the image and send the feedback immediately to the diabetes clinic. Based on the presence or absence of DR the patients will be referred to the eye hospital for detailed retinal examination.

OTHER

Conventional referral

All eligible patients in the conventional arm will be counselled on the importance of eye screening and will be referred to the eye hospital

Sponsors & Collaborators

  • London School of Hygiene and Tropical Medicine

    collaborator OTHER

  • Aravind Eye Care System

    lead OTHER

Principal Investigators

  • Sanil Joseph, MHA, MSc · Lions Aravind Institute of Community Ophthalmology, Aravind Eye Hospital, Madurai, India

  • Ramasamy Kim, DO, DNB · Aravind Eye Hospital, Madruai, India

  • Thulasiraj Ravilla, MBA · Lions Aravind Institute of Community Ophthalmology, Aravind Eye Hospital, Madurai

  • Astrid Fletcher, MSc, PhD · London School of Hygiene and Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-01-31
Completion
2015-03-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02085681 on ClinicalTrials.gov